13907-82-9

Basic information

• Product Name: (R)-2-Benzyloxycarbonylamino-4-carbamoyl-butyric acid methyl ester
• CAS NO: 13907-82-9
• Molecular Weight: 294.307
• Mol File: 13907-82-9.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: (R)-2-Benzyloxycarbonylamino-4-carbamoyl-butyric acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-Benzyloxycarbonylamino-4-carbamoyl-butyric acid methyl ester(13907-82-9)
• EPA Substance Registry System: (R)-2-Benzyloxycarbonylamino-4-carbamoyl-butyric acid methyl ester(13907-82-9)

Safety Data

• Hazardous Substances Data: 13907-82-9(Hazardous Substances Data)

Upstream product

• 50516-14-8 Nα-benzyloxycarbonyl-glutamine 
• 74-88-4 methyl iodide 
• 501-53-1 benzyl chloroformate 
• 56-85-9 L-glutamine 
• 4668-37-5 N-(benzyloxycarbonyl)asparagine methyl ester 
• 501035-53-6 Z-Asn(Trt)-OMe 
• 2650-64-8 Cbz-L-Gln 
• 79-20-9 acetic acid methyl ester 
• 5672-83-3 Z-L-GluOMe 
• 67-56-1 methanol 
• 186581-53-3 diazomethane 

Downstream Products

• 4008-03-1 N²-benzyloxycarbonyl-L-glutamine hydrazide 
• 32668-14-7 L-glutamine methyl ester monohydrochloride 
• 24666-55-5 3-(benzyloxycarbonyl)-amino-2,6-dioxopiperidine 
• 67436-17-3 dimethyl (S)-N-(benzyloxycarbonyl)glutamate 
• 5672-83-3 Z-L-GluOMe 
• 75857-94-2 (5S)-N-(benzyloxycarbonyl)-5-methoxycarbonyl-2-pyrrolidinone 
• 15366-19-5 methyl (S)-2-benzyloxycarbonylamino-6-diazo-5-oxohexanoate 
• 917507-80-3 (2S,5S)-N-[(benzyloxy)carbonyl]-5-hydroxy-2-piperidinecarboxylic acid 
• 117836-15-4 (S)-2-Benzyloxycarbonylamino-5-ethoxycarbonyloxy-5-oxo-pentanoic acid methyl ester 
• 117836-26-7 cis-5(S)-hydroxy-2(S)-N₁-benzyloxycarbonylpipecolic acid methyl ester 
• 117836-13-2 (S)-5-Oxo-piperidine-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester 
• 63088-78-8 (2S,5R)-5-hydroxypiperidine-2-carboxylic acid 
• 141406-83-9 methyl (2S)-2-[N-(benzyloxycarbonyl)amino]-5-(hydroxy)pentanoate 
• 1417900-18-5 (3S)-N-{[3-(benzyloxycarbonyl)amino]-2-oxopiperidin-1-yl}-N-methylcyanamide 

Relevant articles and documents

-

-

A Novel compound

The present invention relates to a novel compound and uses thereof. The novel compound according to the present invention, by inducing the activation of an MKP-1 protein, has an effect of inhibiting inflammatory responses very effectively that occur in respiratory diseases by blocking cell signaling in the order of p38/CK2alpha/NF-kappaB. Accordingly, it is possible to prevent, alleviate or treat the respiratory diseases by oral administration of the novel compound of the present invention.

Substituted 2-(2, 6-Dioxopiperidin-3-yl)-1-method of preparing oxoisoindolines

The present invention concerns new processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines which are useful for preventing or treating diseases or conditions related to an abnormally high level or activity of TNF±. The i

Combinatorial synthesis of 3,5-Dimethylene substituted 1,2,4-Triazoles

Combinatorial cyclizations of imidates and hydrazides with methylene linked R groups, generated from the corresponding nitriles and carboxylic acids, respectively, provided a large library of 3,5-dimethylene substituted 1,2,4- trizoles. 2011 Bentham Science Publishers Ltd.